61 related articles for article (PubMed ID: 25465598)
21. Evaluation of the hypothalamic-pituitary-adrenal axis in a case series of familial partial lipodystrophy.
Elias CP; Antunes DE; Coelho MS; de Lima CL; Rassi N; de Melo APM; Amato AA
Diabetol Metab Syndr; 2019; 11():1. PubMed ID: 30622652
[TBL] [Abstract][Full Text] [Related]
22. The Effects of Leptin Replacement on Neural Plasticity.
Paz-Filho GJ
Neural Plast; 2016; 2016():8528934. PubMed ID: 26881138
[TBL] [Abstract][Full Text] [Related]
23. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
[TBL] [Abstract][Full Text] [Related]
24. New advances in the treatment of generalized lipodystrophy: role of metreleptin.
Rodriguez AJ; Mastronardi CA; Paz-Filho GJ
Ther Clin Risk Manag; 2015; 11():1391-400. PubMed ID: 26396524
[TBL] [Abstract][Full Text] [Related]
25. Leptin applications in 2015: what have we learned about leptin and obesity?
Farr OM; Gavrieli A; Mantzoros CS
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):353-9. PubMed ID: 26313897
[TBL] [Abstract][Full Text] [Related]
26. Leptin-replacement therapy for lipodystrophy.
Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
[TBL] [Abstract][Full Text] [Related]
27. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
[TBL] [Abstract][Full Text] [Related]
28. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
29. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P
Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
[TBL] [Abstract][Full Text] [Related]
30. Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints.
RodrÃguez AJ; Neeman T; Giles AG; Mastronardi CA; Paz Filho G
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):783-97. PubMed ID: 25465598
[TBL] [Abstract][Full Text] [Related]
31. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
[TBL] [Abstract][Full Text] [Related]
32. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.
Gorden P; Park JY
Arch Physiol Biochem; 2006 Apr; 112(2):114-8. PubMed ID: 16931453
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
